From NMDA Receptor Antagonism to Cerebrovascular Effects: The Dual Facets of Nitrous Oxide in Bipolar Depression
European Psychiatry April 1, 2025 C. Pinheiro Ramos, A. F. Reis, C. Batista et al.
IntroductionNitrous oxide (N2O) was first discovered in 1772 by Joseph Priestley. Since its anesthetic properties were realized in 1844, it has been used in the medical and dental fields. Nitrous oxide is also known as “laughing gas” or “nos”.Recent literature suggests that studying N2O is important, not only for understanding the pathophysiology of bipolar depression but also for exploring its...